相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment
Kristine A. Frerichs et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)
L. Drgona et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Severe cytomegalovirus enterocolitis developing following daratumumab exposure in three patients with multiple myeloma
Noa Lavi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
CD38 antibodies in multiple myeloma: back to the future
Niels W. C. J. van de Donk et al.
BLOOD (2018)
Cytomegalovirus reactivation in patients with multiple myeloma
Tetsuo Hasegawa et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Jakub Krejcik et al.
BLOOD (2016)
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
M. A. Dimopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
Michael J. Cannon et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
分享论文
